TrialThe Journal of antimicrobial chemotherapy2023

Efficacy and safety of ceftazidime/avibactam in patients with infections caused by β-lactamase-producing Gram-negative pathogens: a pooled analysis from the Phase 3 clinical trial programme.

Antoni Torres et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.